Loading the section
Company reports as filed with the U.S. Securities and Exchange Commission.
| Metric | 31 Jan 2026 | 31 Jan 2025 |
|---|---|---|
| Revenue | 3.20B | 2.75B |
| Cost of revenue | 782M | 700M |
| Gross profit | 2.41B | 2.05B |
| Research and development | 767M | 693M |
| Selling, general and administrative | 301M | 266M |
| Operating expenses | 1.50B | 1.36B |
| Operating income | 916M | 691M |
| Pre-tax income | 1.19B | 919M |
| Income tax | 286M | 205M |
| Net income | 909M | 714M |
| Earnings per share | 5.55 | 4.41 |
| Earnings per share, diluted | 5.44 | 4.32 |
| Weighted average shares | 164M | 162M |
| Weighted average shares, diluted | 167M | 165M |
| Metric | 30 Apr 2026 | 31 Jan 2026 | 31 Oct 2025 | 31 Jul 2025 | 30 Apr 2025 | 31 Jan 2025 | 31 Oct 2024 | 31 Jul 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 1.90B | 1.42B | 1.66B | 1.93B | 1.96B | 1.12B | 1.04B | 1.17B |
| Receivables | 568M | 1.26B | 314M |
| Metric | 31 Jan 2026 | 31 Jan 2025 |
|---|---|---|
| Operating cash flow | 1.42B | 1.09B |
| Share-based compensation | 473M | 437M |
| Investing cash flow | −1.10B | −700M |
| Share buybacks | 170M | 0 |
| Financing cash flow | −9M | 26M |
Amounts in USD unless stated otherwise. Data: US exchange trading and company filings with the regulator
| 422M |
| 493M |
| 1.02B |
| 256M |
| 365M |
| Current assets | 8.06B | 8.00B | 7.11B | 6.99B | 6.71B | 6.31B | 5.45B | 5.37B |
| Property, plant and equipment | 73M | 70M | 66M | 61M | 59M | 56M | 56M | 57M |
| Goodwill | 488M | 440M | 440M | 440M | 440M | 440M | 440M | 440M |
| Total assets | 9.13B | 8.98B | 8.10B | 8.00B | 7.77B | 7.34B | 6.45B | 6.33B |
| Current liabilities | 1.70B | 1.64B | 945M | 1.26B | 1.46B | 1.40B | 857M | 1.07B |
| Total liabilities | 1.83B | 1.76B | 1.06B | 1.36B | 1.55B | 1.51B | 951M | 1.15B |
| Equity | 7.30B | 7.21B | 7.04B | 6.64B | 6.21B | 5.83B | 5.50B | 5.18B |
| Shares outstanding | 163M | 164M | 164M | 164M | 163M | 163M | 162M | 162M |
| Shares issued | — | 164M | — | — | — | 163M | — | — |